The E2F transcriptional network: old acquaintances with new faces

The E2 factor (E2F) family of transcription factors are downstream targets of the retinoblastoma protein. E2F factors have been known for several years to be important regulators of S-phase entry. Recent studies have improved our understanding of the molecular mechanisms of action used by this transcriptional network. In addition, they have given us an appreciation of the fact that E2F has functions that reach beyond G1/S control and impact cell proliferation in several different ways. The discovery of new family members with unusual properties, the unexpected phenotypes of mutant animals, a diverse collection of biological activities, a large number of new putative target genes and the new modes of transcriptional regulation have all contributed to an increasingly complex view of E2F function. In this review, we will discuss these recent developments and describe how they are beginning to shape a new and revised picture of the E2F transcriptional program.

[1]  M. Vidal,et al.  RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. , 1996, Genes & development.

[2]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[3]  S. Lowe,et al.  Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence , 2003, Cell.

[4]  A. Papavassiliou,et al.  Transcription factor E2F‐1 acts as a growth‐promoting factor and is associated with adverse prognosis in non‐small cell lung carcinomas , 2002, The Journal of pathology.

[5]  Joseph B. Rayman,et al.  E2F4 loss suppresses tumorigenesis in Rb mutant mice. , 2002, Cancer cell.

[6]  K. Helin,et al.  E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription , 1998, Oncogene.

[7]  D. Johnson,et al.  Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[9]  J. Diehl,et al.  The Cyclin D1-dependent Kinase Associates with the Pre-replication Complex and Modulates RB·MCM7 Binding* , 2003, The Journal of Biological Chemistry.

[10]  N. Dyson,et al.  Molecular mechanisms of E2F-dependent activation and pRB-mediated repression , 2004, Journal of Cell Science.

[11]  J. Nevins,et al.  E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. , 1995, Genes & development.

[12]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[13]  J. Trimarchi,et al.  E2F-6, a member of the E2F family that can behave as a transcriptional repressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Nevins,et al.  Distinct roles for E2F proteins in cell growth control and apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Rutka,et al.  The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells , 1998, Oncogene.

[16]  S. Kondo,et al.  Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. , 2004, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[17]  D. Livingston,et al.  Multiple members of the E2F transcription factor family are the products of oncogenes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Vidal,et al.  E2Fs and the Retinoblastoma Protein Family , 1997 .

[19]  T. Jacks,et al.  Tumor Induction and Tissue Atrophy in Mice Lacking E2F-1 , 1996, Cell.

[20]  Arthur P. Young,et al.  Differential regulation of apoptotic genes by Rb in human versus mouse cells , 2004, Oncogene.

[21]  Andrew J. Bannister,et al.  Rb targets histone H3 methylation and HP1 to promoters , 2001, Nature.

[22]  T. Sawado,et al.  dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster. , 1998, Biochemical and biophysical research communications.

[23]  K. Helin,et al.  DcE2F, a Functional Plant E2F-like Transcriptional Activator from Daucus carota * , 2000, The Journal of Biological Chemistry.

[24]  M. Sundaram,et al.  Caenorhabditis elegans lin-35/Rb, efl-1/E2F and Other Synthetic Multivulva Genes Negatively Regulate the Anaphase-Promoting Complex Gene mat-3/APC8 , 2004, Genetics.

[25]  N. Nath,et al.  Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases , 2003, Oncogene.

[26]  H. Cam,et al.  Emerging roles for E2F: beyond the G1/S transition and DNA replication. , 2003, Cancer cell.

[27]  Jiri Bartek,et al.  Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex , 1999, Nature.

[28]  C. Bergounioux,et al.  The E2F Family of Transcription Factors from Arabidopsis thaliana , 2002, The Journal of Biological Chemistry.

[29]  J. Nevins,et al.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes , 1995, Molecular and cellular biology.

[30]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[31]  T. Jacks,et al.  The retinoblastoma gene family in differentiation and development , 1999, Oncogene.

[32]  J. Nevins,et al.  Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Altura,et al.  Inactivation of E2F3 results in centrosome amplification. , 2003, Cancer cell.

[34]  E. Harlow,et al.  The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.

[35]  Andrew J. Bannister,et al.  An E2F-like repressor of transcription , 1997, Nature.

[36]  B. Edgar,et al.  Negative Regulation of dE2F1 by Cyclin-Dependent Kinases Controls Cell Cycle Timing , 2004, Cell.

[37]  D. Monté,et al.  Human E2F6 is alternatively spliced to generate multiple protein isoforms. , 2004, Biochemical and biophysical research communications.

[38]  J. Albrecht,et al.  E2F/p107 and E2F/p130 complexes are regulated by C/EBPα in 3T3-L1 adipocytes , 1999 .

[39]  A. Di Cristofano,et al.  Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors. , 2002, Biochemical and biophysical research communications.

[40]  B. Porse,et al.  E2F Repression by C/EBPα Is Required for Adipogenesis and Granulopoiesis In Vivo , 2001, Cell.

[41]  C. Bergounioux,et al.  AtE2F-a and AtDP-a, members of the E2F family of transcription factors, induce Arabidopsis leaf cells to re-enter S phase , 2002, Molecular Genetics and Genomics.

[42]  Karen H. Vousden,et al.  p14ARF links the tumour suppressors RB and p53 , 1998, Nature.

[43]  Eric B Haura,et al.  Direct repression of the Mcl-1 promoter by E2F1 , 2002, Oncogene.

[44]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[45]  M. Lindström,et al.  Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts , 2003, Oncogene.

[46]  A. Harel-Bellan,et al.  The Rb/chromatin connection and epigenetic control: opinion , 2001, Oncogene.

[47]  S. Kosugi,et al.  E2Ls, E2F-like Repressors of Arabidopsis That Bind to E2F Sites in a Monomeric Form* , 2002, The Journal of Biological Chemistry.

[48]  M. Yaniv,et al.  Oncogenes as Transcriptional Regulators , 1997, Progress in Gene Expression.

[49]  N. Dyson,et al.  Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye. , 1996, The EMBO journal.

[50]  J. Nevins,et al.  The E2F1–3 transcription factors are essential for cellular proliferation , 2001, Nature.

[51]  D. Ginsberg,et al.  Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis* , 2004, Journal of Biological Chemistry.

[52]  J. Cleveland,et al.  E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation , 2001, Oncogene.

[53]  J. Harbour,et al.  Chromatin remodeling and Rb activity. , 2000, Current opinion in cell biology.

[54]  G. Darlington,et al.  C/EBPα Regulates Formation of S-Phase-Specific E2F-p107 Complexes in Livers of Newborn Mice , 1999, Molecular and Cellular Biology.

[55]  W. Kaelin,et al.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation , 2000, Nature.

[56]  J. Jorcano,et al.  Opposite Functions for E2F1 and E2F4 in Human Epidermal Keratinocyte Differentiation* , 2000, The Journal of Biological Chemistry.

[57]  J. Massagué,et al.  E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.

[58]  M. Oberley,et al.  E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9* , 2003, Journal of Biological Chemistry.

[59]  J. Trimarchi,et al.  The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Slack,et al.  Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. , 2004, Cancer cell.

[61]  T. Akiyama,et al.  Phosphorylated retinoblastoma protein stimulates DNA polymerase α , 1997, Oncogene.

[62]  J. Nevins,et al.  E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis , 1995, Journal of virology.

[63]  Chung F. Wong,et al.  E2F Modulates Keratinocyte Squamous Differentiation , 2003, Journal of Biological Chemistry.

[64]  N. Dyson,et al.  A revised picture of the E2F transcriptional network and RB function. , 2002, Current opinion in cell biology.

[65]  D. Dean,et al.  Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.

[66]  A. Koff,et al.  Cell-cycle inhibitors: three families united by a common cause. , 2000, Gene.

[67]  R. Bernards,et al.  E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains , 2004, Oncogene.

[68]  Rakesh Nagarajan,et al.  Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway , 2003, Oncogene.

[69]  N. Dyson,et al.  DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Livingston,et al.  Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[71]  David I. Smith,et al.  Role for the p53 homologue p73 in E2F-1-induced apoptosis , 2000, Nature.

[72]  John S. Satterlee,et al.  Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes , 2004, Cell.

[73]  Jeffrey M. Trimarchi,et al.  Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.

[74]  Ituro Inoue,et al.  Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor , 2004, Oncogene.

[75]  R. Wooster,et al.  Amplification and overexpression of E2F3 in human bladder cancer , 2004, Oncogene.

[76]  Rosalind Eeles,et al.  Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome , 2004, Oncogene.

[77]  H. Endo,et al.  Apaf-1 Is a Mediator of E2F-1-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[78]  S. Thorgeirsson,et al.  Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis , 2000, Oncogene.

[79]  S. Awad,et al.  Aging Reduces Proliferative Capacities of Liver by Switching Pathways of C/EBPα Growth Arrest , 2003, Cell.

[80]  B. Kennedy,et al.  Opposing roles of pRB and p107 in adipocyte differentiation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Ronald Berezney,et al.  The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells , 2002, Journal of Cell Science.

[82]  M. Greenberg,et al.  Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. , 2001, Immunity.

[83]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[84]  A. de Bruin,et al.  Identification and Characterization of E2F7, a Novel Mammalian E2F Family Member Capable of Blocking Cellular Proliferation* , 2003, Journal of Biological Chemistry.

[85]  Yan Geng,et al.  Cyclin E Ablation in the Mouse , 2003, Cell.

[86]  P. Farnham,et al.  The identification of E2F1-specific target genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[87]  T. Yuan,et al.  The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[88]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Nevins,et al.  Oncogenic capacity of the E2F1 gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Greenberg,et al.  E2F-1 Functions in Mice to Promote Apoptosis and Suppress Proliferation , 1996, Cell.

[91]  C. Conti,et al.  Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development , 1998, Oncogene.

[92]  G. Sauter,et al.  E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer , 2004, Oncogene.

[93]  R. Bronson,et al.  E2F4 is essential for normal erythrocyte maturation and neonatal viability. , 2000, Molecular cell.

[94]  Pearlly S Yan,et al.  Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase , 2003, Oncogene.

[95]  N. Dyson,et al.  p107 and p130: versatile proteins with interesting pockets. , 2001, Experimental cell research.

[96]  M. Azadniv,et al.  The E2F-1 Transcription Factor Promotes Caspase-8 and Bid Expression, and Enhances Fas Signaling in T Cells1 , 2004, The Journal of Immunology.

[97]  J. Nevins,et al.  Specificity in the activation and control of transcription factor E2F-dependent apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[98]  D. Ginsberg,et al.  E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress* , 2003, The Journal of Biological Chemistry.

[99]  David S. Park,et al.  The Proapoptotic Gene SIVA Is a Direct Transcriptional Target for the Tumor Suppressors p53 and E2F1* , 2004, Journal of Biological Chemistry.

[100]  K. Akashi,et al.  Mouse Development and Cell Proliferation in the Absence of D-Cyclins , 2004, Cell.

[101]  R. Bronson,et al.  Dp1 is required for extra-embryonic development , 2003, Development.